CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
40.71
+2.71 (7.13%)
At close: Oct 8, 2025, 4:00 PM EDT
41.29
+0.58 (1.42%)
After-hours: Oct 8, 2025, 7:45 PM EDT
CG Oncology Market Cap
CG Oncology has a market cap or net worth of $3.10 billion as of October 8, 2025. Its market cap has increased by 18.66% in one year.
Market Cap
3.10B
Enterprise Value
2.49B
1-Year Change
18.66%
Ranking
Category
Stock Price
$40.71
Market Cap Chart
Since the IPO on January 25, 2024, CG Oncology's market cap has increased from $1.21B to $3.10B, an increase of 157.35%. That is a compound annual growth rate of 74.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 2.90B | 32.70% |
| Dec 31, 2024 | 2.18B | 81.02% |
| Jan 25, 2024 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.36B |
| Johnson & Johnson | 454.91B |
| AbbVie | 411.31B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |